Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence | MicrobiomeTrials← Back to trialsNCT05266807
Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2023-03-15Est. Completion: 2027-04-01
Enrollment target: 100 participants Locations- Universitätsspital, Basel, Basel, Switzerland
- Inselspital Bern, Bern, Canton of Bern, Switzerland
- HFR Fribourg - Hôpital cantonal, Fribourg, Canton of Fribourg, Switzerland
- Hirslanden Klinik St Anna, Lucerne, Canton of Lucerne, Switzerland
- Kantonsspital St Gallen, HOCH, Sankt Gallen, Canton of St. Gallen, Switzerland
- CHUV, Lausanne, Canton of Vaud, Switzerland
- Universitätsspital Zürich, Zurich, Canton of Zurich, Switzerland
- Institut central des hôpitaux, Sion, Valais, Switzerland
Other microbiome trials you might be interested in
Clostridium DifficileClostridium Difficile InfectionsClostridium Difficile Infection RecurrenceClostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceCDIC. Diff InfectionRecurrent Clostridium Difficile InfectionC.Difficile DiarrheaDiarrhea Infectious
The overall objective of the RESTORATiVE303 study is to evaluate the safety and the Clostridioides difficile infection (…
Huntsville, United StatesEst. completion Jun 2027
The gut microbiota plays a crucial role in human health, influencing metabolism, immunity, and pathogen resistance. Rese…
Rome, ItalyEst. completion Mar 10, 2027
Clostridium Difficile Infection
This is a Phase 1, first-in-human, double-blind, placebo-controlled, adaptive-design, single-site study, involving dose …
Multiple LocationsEst. completion Aug 22, 2028